Vaxcyte Inc (NASDAQ: PCVX) established initial surge of 5.22% at $63.71, before settling in for the price of $60.55 at the close. Taking a more long-term approach, PCVX posted a 52-week range of $42.98-$82.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -46.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -2.56%. This publicly-traded company’s shares outstanding now amounts to $108.76 million, simultaneously with a float of $103.22 million. The organization now has a market capitalization sitting at $6.93 billion. At the time of writing, stock’s 50-day Moving Average stood at $67.31, while the 200-day Moving Average is $57.82.
Vaxcyte Inc (PCVX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Vaxcyte Inc industry. Vaxcyte Inc’s current insider ownership accounts for 5.09%, in contrast to 91.41% institutional ownership. According to the most recent insider trade that took place on Apr 23 ’24, this organization’s CHIEF EXECUTIVE OFFICER sold 15,000 shares at the rate of 61.92, making the entire transaction reach 928,845 in total value, affecting insider ownership by 477,847. Preceding that transaction, on Apr 18 ’24, Company’s PRESIDENT AND CFO sold 8,000 for 61.27, making the whole transaction’s value amount to 490,199. This particular insider is now the holder of 95,679 in total.
Vaxcyte Inc (PCVX) Earnings and Revenue Records
Vaxcyte Inc’s EPS decrease for this current 12-month fiscal period is -2.56% and is forecasted to reach -4.51 in the upcoming year.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Let’s observe the current performance indicators for Vaxcyte Inc (PCVX). It’s Quick Ratio in the last reported quarter now stands at 7.54. The Stock has managed to achieve an average true range (ATR) of 2.29.
In the same vein, PCVX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.21, a figure that is expected to reach -1.13 in the next quarter, and analysts are predicting that it will be -4.51 at the market close of one year from today.
Technical Analysis of Vaxcyte Inc (PCVX)
Now, what If we examine the latest scores posted by [Vaxcyte Inc, PCVX]. During the last 5-days, its volume was lower the volume of 0.83 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 64.70% While, its Average True Range was 2.29.
Raw Stochastic average of Vaxcyte Inc (PCVX) in the period of the previous 100 days is set at 35.02%, which indicates a major fall in contrast to 86.84% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 33.68% that was lower than 39.38% volatility it exhibited in the past 100-days period.
